130 results
NT 10-Q
AUTL
Autolus Therapeutics plc
13 May 24
Notice of late quarterly filing
9:33am
-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. All statements other
8-K
EX-99.1
AUTL
Autolus Therapeutics plc
1 Apr 24
Departure of Directors or Certain Officers
7:06am
of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements
10-K
2023 FY
AUTL
Autolus Therapeutics plc
21 Mar 24
Annual report
4:55pm
; litigation (including class claims) and mass arbitration demands; fines and penalties; disruptions of our business operations; reputational harm; loss … is more common than in the United States;
Table of contents
litigation or administrative actions resulting from claims against us by current or former
10-K
2023 FY
EX-10.12
AUTL
Autolus Therapeutics plc
21 Mar 24
Annual report
4:55pm
necessary for such Party to initiate litigation under Section 11.4(b). Notwithstanding the foregoing, [***] shall not settle any Competitive … Infringement in a manner that [***], without the express written consent of [***]. (d) Recovery. Any recovery realized as a result of such litigation described
8-K/A
EX-99.1
AUTL
Autolus Therapeutics plc
15 Mar 24
Results of Operations and Financial Condition
4:21pm
provisions of the Private Securities Litigation Reform Act of 1995. These may include, but are not limited to statements regarding the status of clinical
8-K
EX-99.2
60xf6z87fum 833
14 Mar 24
Results of Operations and Financial Condition
12:32pm
8-K
EX-99.1
x3dmih3
14 Mar 24
Results of Operations and Financial Condition
12:32pm
8-K
EX-99.1
2gx4pfe ls
13 Feb 24
Regulation FD Disclosure
4:06pm
424B5
3xhay9
9 Feb 24
Prospectus supplement for primary offering
5:15pm
8-K
EX-99.1
m091 oa54wrtqz
8 Feb 24
Autolus Announces Pricing of Underwritten Offering
4:17pm
8-K
EX-10.2
evizxaf0hu4j4uon
8 Feb 24
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs
6:06am
8-K
EX-10.1
j8xn50u70h2vhm jo5r
8 Feb 24
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs
6:06am
8-K
EX-99.1
oq37ev0gbp77us7
8 Feb 24
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs
6:06am
S-3ASR
woncnme2l31qx0rsd3
7 Feb 24
Automatic shelf registration
10:00pm
S-3ASR
EX-4.7
v28hce9a npqliz
7 Feb 24
Automatic shelf registration
10:00pm
8-K
EX-99.1
b5kgna9wu2qb
26 Jan 24
Regulation FD Disclosure
1:02pm
8-K
EX-99.2
ycbm596ajay 7b2k
11 Dec 23
Regulation FD Disclosure
8:31am
8-K
EX-99.1
ht43i1k28otnq5t bt4
11 Dec 23
Regulation FD Disclosure
8:31am
8-K
EX-99.1
oc2bpas
27 Nov 23
Regulation FD Disclosure
7:07am
10-Q
fi1ncna xt02mvgef
9 Nov 23
Quarterly report
4:18pm